Rare diseases
Investigational molecules
Locations
Back to Germany1 770 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Eptacog Alfa for Treating Acute Hemorrhagic Stroke in Patients with Brain Bleeding
GermanyStudy on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination
GermanyGermanyStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
GermanyStudy on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Dominant or Mixed-Type Irritable Bowel Syndrome
GermanyStudy on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Predominant Irritable Bowel Syndrome
GermanyStudy on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli
GermanyLong-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2
GermanyStudy on VE303 for Preventing Recurrent C. difficile Infection in Patients
GermanyStudy of Ruxolitinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with IL-7R/JAK-STAT Pathway Mutations
GermanyStudy of Brigatinib for Children and Young Adults with ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors, or Other Solid Tumors
GermanyStudy on Reducing Inflammation in Acute Ischemic Stroke Patients Using Dornase Alfa and Sodium Chloride
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
